Drug & intervention

sorafenib

RxCUI 495881

Clinical trials35
Recruiting1
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

35 shown
SNF Platform Study of HR+/ HER2-advanced Breast CancerNCT05594095 · 2022-12-30
RECRUITING
Efficacy and Safety of Sorafenib in New-Onset Type 1 Diabetes MellitusNCT06227221 · 2026-02-01
NOT_YET_RECRUITING
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialNCT03878524 · 2020-04-01
TERMINATED
Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular CarcinomaNCT01171482 · 2015-11-01
TERMINATED
Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM)NCT01724606 · 2012-11-05
COMPLETED
Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal TumorsNCT01640665 · 2012-07-01
COMPLETED
The Effect of Sorafenib on Portal PressureNCT01714609 · 2011-08-01
COMPLETED
BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small Cell Lung CancerNCT01248247 · 2011-06-02
COMPLETED
Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction ChemotherapyNCT01159327 · 2010-12-01
TERMINATED
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)NCT01183663 · 2010-08-01
COMPLETED
Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast CancerNCT01194869 · 2010-06-01
TERMINATED
Depocyt® With Sorafenib in Neoplastic MeningitisNCT00964743 · 2009-08-01
TERMINATED
Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung CancerNCT00954278 · 2009-07-28
COMPLETED
Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast CancerNCT00825734 · 2009-03-01
COMPLETED
Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT00754923 · 2008-10-01
TERMINATED
Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast CancerNCT00634634 · 2008-08-11
COMPLETED
Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate CancerNCT00694291 · 2008-06-01
WITHDRAWN
Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung CancerNCT00870532 · 2008-06-01
COMPLETED
Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid TumorsNCT00703638 · 2008-05-01
COMPLETED
Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on ErlotinibNCT00609804 · 2008-03-01
COMPLETED
Phase I Study of Vorinostat and Sorafenib in Advanced CancerNCT00635791 · 2008-03-01
COMPLETED
Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung CancerNCT00543335 · 2008-01-25
TERMINATED
Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast CancerNCT00525161 · 2007-10-01
TERMINATED
A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast CancerNCT00632541 · 2007-10-01
TERMINATED
Sorafenib in Resected Non-small Cell Lung CarcinomaNCT00532025 · 2007-09-01
TERMINATED
Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung CancerNCT00417248 · 2007-06-01
TERMINATED
1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) TherapyNCT00493636 · 2007-06-01
COMPLETED
Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)NCT00452387 · 2007-05-01
TERMINATED
Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast CancerNCT00544167 · 2007-05-01
COMPLETED
Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung CancerNCT00466232 · 2007-04-01
COMPLETED
Sorafenib in BAC or Never-Smokers With Lung AdenocarcinomaNCT00456716 · 2007-03-01
COMPLETED
Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)NCT00452218 · 2007-03-01
COMPLETED
Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate CancerNCT00414388 · 2006-12-01
COMPLETED
BATTLE Program: Sorafenib in Patients With NSCLCNCT00411671 · 2006-11-01
COMPLETED
Sorafenib in Treating Patients With Refractory Non-Small Cell Lung CancerNCT00064350 · 2004-06-28
COMPLETED

Conditions being studied

Lung Cancer8Breast Cancer7Metastatic Breast Cancer4Non-Small Cell Lung Cancer3Prostate Cancer3Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive1Advanced Breast Cancer1Advanced Cancers1Anatomic Stage IV Breast Cancer AJCC v81Anemia1Ann Arbor Stage III Hodgkin Lymphoma1Ann Arbor Stage III Non-Hodgkin Lymphoma1Ann Arbor Stage IV Hodgkin Lymphoma1Ann Arbor Stage IV Non-Hodgkin Lymphoma1Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative1Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive1Brain Metastases1Breast Neoplasm1Carcinoma, Hepatocellular1Carcinoma, Non Small Cell Lung1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.